Van Aalderen, M C <br/><br/>
Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Jan 2011 
 - 223-6 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/j.1538-7836.2010.04133.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers--blood<br/>Blood Coagulation--drug effects<br/>Blood Coagulation Tests<br/>Cell-Derived Microparticles--drug effects<br/>Female<br/>Flow Cytometry<br/>Granulocyte Precursor Cells--drug effects<br/>Humans<br/>Leukemia, Myeloid, Acute--blood<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Thrombin--metabolism<br/>Thrombosis--blood<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult